ATE358139T1 - Verfahren zur herstelllung von gonadotropin- zusammensetzungen - Google Patents

Verfahren zur herstelllung von gonadotropin- zusammensetzungen

Info

Publication number
ATE358139T1
ATE358139T1 AT00926922T AT00926922T ATE358139T1 AT E358139 T1 ATE358139 T1 AT E358139T1 AT 00926922 T AT00926922 T AT 00926922T AT 00926922 T AT00926922 T AT 00926922T AT E358139 T1 ATE358139 T1 AT E358139T1
Authority
AT
Austria
Prior art keywords
gonadotropins
menotropins
follitropin
fsh
protein
Prior art date
Application number
AT00926922T
Other languages
English (en)
Inventor
Band Claudio Fernand Wolfenson
Liliana Ester Balanian
Jose Felipe Groisman
Erundina Marta Fasanella
Original Assignee
Inst Massone S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Massone S A filed Critical Inst Massone S A
Application granted granted Critical
Publication of ATE358139T1 publication Critical patent/ATE358139T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00926922T 1999-04-16 2000-04-14 Verfahren zur herstelllung von gonadotropin- zusammensetzungen ATE358139T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12954099P 1999-04-16 1999-04-16

Publications (1)

Publication Number Publication Date
ATE358139T1 true ATE358139T1 (de) 2007-04-15

Family

ID=22440494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926922T ATE358139T1 (de) 1999-04-16 2000-04-14 Verfahren zur herstelllung von gonadotropin- zusammensetzungen

Country Status (13)

Country Link
EP (1) EP1169349B1 (de)
JP (1) JP4574865B2 (de)
AT (1) ATE358139T1 (de)
AU (1) AU779005B2 (de)
BR (1) BRPI0010677B8 (de)
CA (1) CA2370225C (de)
CY (1) CY1107666T1 (de)
DE (1) DE60034117T2 (de)
DK (1) DK1169349T3 (de)
ES (1) ES2284494T3 (de)
MX (1) MXPA01010522A (de)
PT (1) PT1169349E (de)
WO (1) WO2000063248A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754860B2 (en) * 2003-12-22 2010-07-13 Ares Trading S.A. Method for purifying FSH
JP4933439B2 (ja) * 2004-11-09 2012-05-16 アレス トレーディング ソシエテ アノニム Ｆｓｈの精製方法
KR101173717B1 (ko) 2004-11-09 2012-08-13 아레스 트레이딩 에스.에이. Ｆｓｈ를 정제하는 방법
AU2005335900B2 (en) 2005-08-26 2012-03-29 Ares Trading S.A. Process for the preparation of glycosylated interferon beta
CA2625978A1 (en) 2005-12-09 2007-06-14 Ares Trading S.A. Method for purifying fsh or a fsh mutant
EA022993B1 (ru) 2007-06-28 2016-04-29 Рациофарм Гмбх Молекулы нуклеиновой кислоты, кодирующие альфа- и бета-цепи фолликулостимулирующего гормона человека (fsh)
US20110054410A1 (en) 2008-02-08 2011-03-03 Biogenerix Ag Liquid formulation of fsh
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
AU2010234028B2 (en) * 2009-04-01 2013-11-14 Theramex HQ UK Limited Method for purifying recombinant FSH
EP2325194A1 (de) 2009-11-24 2011-05-25 Glycotope GmbH Verfahren zur Reinigung von Glykoproteinen
CN103159846B (zh) * 2013-04-09 2015-04-22 邹平县滨渤生物科技有限公司 Hmg粗品的制备方法
US9920107B2 (en) 2014-05-23 2018-03-20 Instituto Massone S.A. Process for obtaining HMG-UP (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants
SI3261661T1 (sl) 2015-02-26 2024-03-29 Ferring B.V. Menotropin za zdravljenje neplodnosti
CN108070640B (zh) * 2018-01-12 2021-09-21 浙江省农业科学院 一种与卵泡刺激素剂量呈线性相关的基因的筛选方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3819M (fr) * 1963-03-11 1966-01-10 Serono Ist Farm Nouvelle hormone hypophysaire a activité différenciée.
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh

Also Published As

Publication number Publication date
MXPA01010522A (es) 2003-08-19
JP4574865B2 (ja) 2010-11-04
DK1169349T3 (da) 2007-07-30
CA2370225C (en) 2010-06-29
DE60034117T2 (de) 2007-12-13
BRPI0010677B8 (pt) 2021-05-25
JP2002542260A (ja) 2002-12-10
ES2284494T3 (es) 2007-11-16
CY1107666T1 (el) 2013-04-18
AU779005B2 (en) 2004-12-23
DE60034117D1 (de) 2007-05-10
EP1169349B1 (de) 2007-03-28
EP1169349A2 (de) 2002-01-09
AU4549100A (en) 2000-11-02
BR0010677A (pt) 2002-02-05
WO2000063248A2 (en) 2000-10-26
BR0010677B1 (pt) 2013-04-30
WO2000063248A3 (en) 2001-02-01
CA2370225A1 (en) 2000-10-26
PT1169349E (pt) 2007-06-18

Similar Documents

Publication Publication Date Title
CY1107666T1 (el) Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης
Al-Obeidi et al. Potent and prolonged-acting cyclic lactam analogs of. alpha.-melanotropin: design based on molecular dynamics
Jackson et al. The Primary Structure of Porcine Pancreatic Ribonuclease: I. THE DISTRIBUTION AND SITES OF CARBOHYDRATE ATTACHMENT
Rattenholl et al. Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor
Low et al. Chemical characterization of thymosin beta 4.
DE69122611T2 (de) Methoden und reagentien für die identifikation, charakterisierung und inhibition von farnesyl-protein-transferase
EP0605489A1 (de) Modifizierte peptidderivate
PL366364A1 (en) Process for producing peptides by using in vitrotranscription/translation system
JP2002530059A (ja) 輸送ベクター
AU1083195A (en) Conotoxin peptides
Wang et al. Revisiting oxytocin through the medium of isonitriles
Butler et al. Chemical studies on the cyanogen bromide peptides of rat skin collagen. Amino acid sequence of α1-CB4
Dadlez et al. A third native one-disulphide intermediate in the folding of bovine pancreatic trypsin inhibitor
EP1258494A1 (de) Multiprotein-Komplexe von Eukaryonten
JPS61109798A (ja) ペプチドの製造及び精製方法
Cruz et al. “One-Pot” preparation of N-carbamate protected amino acids via the azide
DE69708420T2 (de) Herstellung von gereinigten (Poly)Peptiden
DE60310958T2 (de) Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen
Spetzler et al. A novel strategy for the synthesis of the cysteine‐rich protective antigen of the malaria merozoite surface protein (MSP‐1) Knowledge‐based strategy for disulfide formation
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
Hekman et al. Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product
EP0700928A1 (de) Nukleinsäuren-bindende Oligomere für Therapie und Diagnostik
Lundquist et al. Synthesis and Human Neurotensin Receptor Binding Activities of Neurotensin (8− 13) Analogues Containing Position 8 α-Azido-N-alkylated Derivatives of Ornithine, Lysine, and Homolysine
Büllesbach et al. Relaxin structure. Quasi allosteric effect of the NH2-terminal A-chain helix.
DK292584A (da) Biologisk aktive konjugater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1169349

Country of ref document: EP